期刊
JOURNAL OF CELLULAR BIOCHEMISTRY
卷 118, 期 6, 页码 1563-1573出版社
WILEY
DOI: 10.1002/jcb.25818
关键词
TRANSCRIPTION FACTOR; MicroRNA-193b-3p; UROTHELIAL CARCINOMA; CHEMOTHERAPEUTIC DRUGS; MIGRATION; CELL CYCLE
资金
- Ministry of Science and Technology [NSC102-2320-B-037-026-, MOST 103-2320-B037-029-]
- Kaohsiung Medical University [KMU-M102008]
- Aim for the Top Universities Grant from Kaohsiung Medical University [KMU-TP103E19, KMU-TP103G00, KMU-TP103G01, KMUTP103G04, KMU-TP103G05]
- Ministry of Health and Welfare [MOHW104-TDU-B-212-124-003]
Transcription factor CCAAT/enhancer-binding protein delta (CEBPD) plays multiple roles in tumor progression. Studies have demonstrated that cisplatin (CDDP) induced CEBPD expression and had led to chemotherapeutic drug resistance. However, the underlying molecular mechanisms of CDDP-regulated CEBPD expression and its relevant roles in CDDP responses remain elusive. MicroRNAs (miRNAs) are small non-coding RNAs that negatively regulate gene expression in a sequence-specific manner. Abnormal miRNAs expression is associated with tumor progression. In current study, a large-scale PCR-based miRNA screening was performed to identify CEBPD-associated miRNAs in urothelial carcinoma cell line NTUB1. Eleven miRNAs were selected with more than twofold changes. MiR-193b-3p, a known tumor suppressor, down-regulated proto-oncogenes Cyclin D1, and ETS1 expression and led to cell cycle arrest, cell invasion, and migration inhibition. The expression of miR-193b-3p was associated with the DNA binding ability of CEBPD in CDDP response. CEBPD knocking-down approach provided a strong evidence of the positive correlation between CEBPD and miR-193b-3p. CDDP-induced CEBPD trans-activated miR-193b-3p expression and it directly targeted the 3-UTR of Cyclin D1 and ETS1 mRNA, and silenced the protein expression. In addition, miR-193b-3p also inhibited cell migration activity, arrested cell at G1 phase, and sensitized NTUB1 to CDDP treatment. In conclusion, this study indicates that CEBPD exhibits an anti-tumorigenic function through transcriptionally activating miR-193b-3p expression upon CDDP treatment. This study provides a new direction for managing human urothelial carcinoma. J. Cell. Biochem. 118: 1563-1573, 2017. (C) 2016 Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据